Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v2.4.0.6
Consolidated Statements of Cash Flows (USD $)
12 Months Ended
Dec. 31, 2011
Dec. 31, 2010
Cash flows from operating activities    
Net (loss) $ (5,457,310) $ (319,813)
Adjustments to reconcile net (loss) to net cash used in operating activities:    
Deferred income taxes 3,272   
Bad debt expense 326,456 554,343
Depreciation and amortization 531,844 432,566
Amortization of financing costs 160,408 7,401
Write-off obsolete inventory 1,439,616   
Gain on change in fair value of derivative liability 281,508   
Equity in loss (earnings) unconsolidated subsidiary 42,677 (55,305)
Non-cash interest expense 758,044   
Changes in assets and liabilities:    
Account receivable-trade 560,353 (650,485)
Inventories (665,914) (62,790)
Prepaid expenses and other current assets (102,031) 43,879
Deferred taxes    (103,005)
Accounts payable 652,240 (58,845)
Accrued expenses and other current liabilities 1,047,884 (49,366)
Net cash used in operating activities (420,953) (261,420)
Cash flows from investing activities    
Purchase of property and equipment (575,430) (357,610)
Cash acquired on business combination 585,720   
Net cash provided by (used in) investing activities 10,290 (357,610)
Cash flows from financing activities    
Proceeds from convertible debt 2,750,000   
Payment of deferred financing costs (150,364)   
Repayment of borrowings from noteholders (2,725,904) (92,223)
Proceeds from sale of common stock 705,000   
Advance from (payment to) shareholder (3,211) 375,321
Net cash provided by financing activities 575,521 283,098
Net increase (decrease) in cash and cash equivalents 164,858 (335,932)
Cash and cash equivalents, beginning of year 251,475 587,407
Cash and cash equivalents, end of year 416,333 251,475
Supplemental disclosures of cash flow information:    
Interest paid 539,616 439,018
Conversion of convertible note payable and acrued interest to common stock $ 509,178